1 / 1

Clinically proven to reduce the risk of DVT | mediven Thrombexin 18 | Pushpanjali medi india pvt ltd

Pushpanjali medi India pvt ltd provide medivenu00ae thrombexinu00ae 18. Anti-embolism stocking with 18 mmHg. Non-slip fit thanks to silicone topband; Breathable and particularly soft antibacterial toe.

pmiplindia
Download Presentation

Clinically proven to reduce the risk of DVT | mediven Thrombexin 18 | Pushpanjali medi india pvt ltd

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Features: 1.Clinically proven to reduce the risk of DVT. 2.In three styles, below knee, thigh length and thigh with waist attachment. 3.With reinforced soft fleecy heel to reduce the risk of pressure sores on the heel. 4.Inspection opening aids checking circulation. 5.And with anti-bacterial thread in toe area, reduces fungal infections. 6.Slip proof silicone top band reduces risk of roll down. http://www.pushpanjaligroup.com/product/mediven-thrombexin-18/

More Related